C

China National Medicines Corp Ltd
SSE:600511

Watchlist Manager
China National Medicines Corp Ltd
SSE:600511
Watchlist
Price: 34.38 CNY -0.12% Market Closed
Market Cap: 25.9B CNY
Have any thoughts about
China National Medicines Corp Ltd?
Write Note

China National Medicines Corp Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China National Medicines Corp Ltd
Capital Expenditures Peer Comparison

Comparables:
1099
601607
600998
000963
Q
301015

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
C
China National Medicines Corp Ltd
SSE:600511
Capital Expenditures
-ÂĄ138.9m
CAGR 3-Years
-27%
CAGR 5-Years
-1%
CAGR 10-Years
-2%
Sinopharm Group Co Ltd
HKEX:1099
Capital Expenditures
-ÂĄ2.8B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-16%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Capital Expenditures
-ÂĄ2.9B
CAGR 3-Years
-5%
CAGR 5-Years
-8%
CAGR 10-Years
-12%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Capital Expenditures
-ÂĄ946.4m
CAGR 3-Years
18%
CAGR 5-Years
5%
CAGR 10-Years
-2%
Huadong Medicine Co Ltd
SZSE:000963
Capital Expenditures
-ÂĄ1.7B
CAGR 3-Years
-7%
CAGR 5-Years
-10%
CAGR 10-Years
-15%
Q
Qingdao Baheal Medical Inc
SZSE:301015
Capital Expenditures
-ÂĄ129.2m
CAGR 3-Years
-99%
CAGR 5-Years
-52%
CAGR 10-Years
N/A

See Also

What is China National Medicines Corp Ltd's Capital Expenditures?
Capital Expenditures
-138.9m CNY

Based on the financial report for Jun 30, 2024, China National Medicines Corp Ltd's Capital Expenditures amounts to -138.9m CNY.

What is China National Medicines Corp Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-2%

Over the last year, the Capital Expenditures growth was 10%. The average annual Capital Expenditures growth rates for China National Medicines Corp Ltd have been -27% over the past three years , -1% over the past five years , and -2% over the past ten years .

Back to Top